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  Abstract 
A unique characteristic of skeletal muscle is its heterogeneous nature and ability to acquire 
new functional characteristics to keep up with changing demands. These plastic properties are 
mainly regulated by activity. Distinct patterns of electrical stimuli, exerted by motorneurons, 
are sufficient to activate separate transcriptional programs that affect muscle strength, speed 
and endurance. Elucidating the molecular pathways linking electrical stimulation to gene 
expression is necessary to explain the effects of training and neuromuscular disorders.  
 
This work presents erythroblastosis virus E26 oncogene homolog 2 (Ets-2) as a possible 
mediator in the signaling network coupling electrical signals to transcriptional responses.  
The Ets-2 protein has been shown to be more abundant in fast muscle, where it selectively 
translocates and binds an enhancer element necessary for transcription of the troponin I fast 
(TnIf) gene. The purpose of this work was to determine the wild type expression pattern of 
the two skeletal troponin I (TnI) genes, and investigate the possible effects of Ets-2 
overexpression and knockdown on TnI isoform distribution. 
 
An expression vector encoding Ets-2 was transfected into the “slow” soleus muscle in rats by 
in vivo electroporation. Myosin heavy chain (MyHC) fiber type distribution and TnI isoform 
expression among the transfected fibers were analyzed, and compared to sham transfected 
and normal controls. In a separate series of experiments, an expression vector encoding 
siRNA against Ets-2 was transfected into the “fast” extensor digitorum longus (EDL). Fiber 
type and TnI distribution among the transfected fibers were analyzed. To investigate a 
possible effect on TnI expression, the fluorescent intensity of the siRNA-transfected fibers 
were measured and compared against normal scramble transfected and normal control fibers. 
 
Mapping of TnI expression showed the slow TnI isoform (TnIs) is confined to slow-twitch 
fibers and TnIf to fast-twitch fibers, however fast-twitch fibers in soleus were shown to co-
express both isoforms. Overexpression of Ets-2 had no effect on TnIf expression or MyHC 
composition. Knockdown of Ets-2 resulted in a 16% reduction of MyHC 2b fibers 
accompanied by 12% increase in 2a fibers. Measurements of TnIf fluorescence showed a 
minor reduction in TnIf staining intensity, however a larger sample material is needed to 
make any certain conclusions. 
 
	   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	  Abbreviations 
ATP Adenosine tri phosphate  
CaM Calmodulin 
CaMK Calmodulin-dependent protein kinase  
Cn Calcineurin 
DMEM Dulbecco’s Modified Eagle Medium  
EDL Extensor digitorum longus  
EMSA Electrophoretic mobility shift assay  
FIRE Fast Intronic Regulatory Element  
GLUT4 Glucose transporter 4  
GTF3 General transcription factor 3  
HDAC Histone deacetylases 
HEK-293 Human embryonic kidney cells 
IRE Internal regulatory element  
mATPase  Myosin ATPase 
MEF2 Myocyte enhancer factor 2  
MRFs Myogenic regulatory factors  
MyHC Myosin heavy chain  
Native PAGE Native polyacrylamide gel electrophoresis  
NFAT Nuclear factor of activated T-Cells  
ORF Open reading frame  
PBS  Phosphate buffered saline 
PNT domain Pointed domain 
RISC RNA induced silencing complex  
RNAi RNA interference 
SERCA Sarco/Endoplasmatic reticulum Ca2+ ATPase  
SiRNA  Small interfering RNA 
SR Sarcoplamatic Reticulum  
SURE Slow Upstream Regulatory Element  
T115 Threonine 115 
TBS Tris-Buffered Saline 
TBS-T  Tris-Buffered Saline Tween 
Tm Tropomyosin 
Tn Troponin complex 
TnC Troponin C 
TnI Troponin I 
TnT Troponin T 
X-Gal 5-bromo-4-chloro-3-indolyl-ß-D-galactoside 
 
 
 
	   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	  Table of content 
1	   Introduction	  .......................................................................................................	  2	  
1.1	   Fiber	  types	  ........................................................................................................................................	  2	  
1.2	   Plasticity	  of	  fiber	  type	  ..................................................................................................................	  4	  
1.3	   Signaling	  pathways	  regulating	  muscle	  plasticity	  ................................................................	  5	  
1.4	   The	  troponin	  complex	  ..................................................................................................................	  7	  
1.5	   Transcriptional	  regulation	  of	  the	  Troponin	  I	  genes	  ..........................................................	  8	  
1.6	   Ets	  Family	  of	  transcription	  Factors	  .......................................................................................	  11	  
1.7	   Ets-­‐2	  .................................................................................................................................................	  11	  
1.8	   Aims	  of	  the	  study	  .........................................................................................................................	  13	  
2	   Materials	  and	  Methods	  .................................................................................	  14	  
2.1	   Overview	  ........................................................................................................................................	  14	  
2.2	   Animal	  experiments	  ...................................................................................................................	  15	  2.2.1	   Animals	  .......................................................................................................................................................	  15	  2.2.2	   Anesthesia	  .................................................................................................................................................	  15	  2.2.3	   Surgical	  procedures	  ..............................................................................................................................	  15	  2.2.4	   In	  vivo	  electroporation	  ........................................................................................................................	  16	  
2.3	   DNA	  constructs	  ............................................................................................................................	  17	  2.3.1	   Ets-­‐2	  expression	  vector	  .......................................................................................................................	  17	  2.3.2	   siRNA	  expression	  vectors	  ..................................................................................................................	  19	  
2.4	   Testing	  of	  DNA	  constructs	  ........................................................................................................	  20	  2.4.1	   Transfection	  in	  cell	  culture	  ................................................................................................................	  20	  2.4.2	   Protein	  isolation	  and	  measurements	  ............................................................................................	  20	  2.4.3	   Native	  PAGE	  and	  Western	  Blotting	  ................................................................................................	  20	  
2.5	   Histochemistry	  ............................................................................................................................	  21	  2.5.1	   Freezing	  of	  muscles	  ..............................................................................................................................	  21	  2.5.2	   Preparation	  of	  muscle	  sections	  ........................................................................................................	  21	  2.5.3	   Staining	  for	  β-­‐galactosidase	  activity	  ..............................................................................................	  21	  2.5.4	   Staining	  for	  MyHC	  isoforms	  ..............................................................................................................	  22	  2.7.1	   Staining	  for	  Troponin	  I	  isoforms	  .....................................................................................................	  23	  
2.9	   Imaging	  ...........................................................................................................................................	  23	  2.9.1	   Bright-­‐field	  imaging	  ..............................................................................................................................	  23	  2.9.2	   Fluorescent	  microscopy	  ......................................................................................................................	  23	  2.9.3	   Quantification	  of	  TnIf	  expression	  ...................................................................................................	  24	  
2.10	   Statistical	  procedures	  .............................................................................................................	  24	  
3	   Results	  ................................................................................................................	  25	  
3.1	   Qualitative	  assessment	  of	  TnI	  expression.	  .........................................................................	  25	  3.1.1	   TnI	  expression	  pattern	  in	  EDL.	  ........................................................................................................	  25	  3.1.2	   TnI	  expression	  in	  hybrid	  fibers	  of	  EDL.	  .......................................................................................	  26	  3.1.3	   TnI	  expression	  pattern	  in	  soleus.	  ....................................................................................................	  27	  
3.2	   Overexpression	  of	  Ets-­‐2	  in	  soleus	  ..........................................................................................	  28	  3.2.1	   Verification	  of	  Ets-­‐2	  expression	  in	  cell	  culture.	  ........................................................................	  28	  3.2.2	   Fiber	  type	  and	  isoform	  distribution	  in	  soleus	  overexpressing	  Ets-­‐2.	  ..............................	  28	  
3.5	   Effects	  of	  siRNA	  mediated	  knock-­‐down	  in	  EDL	  .................................................................	  29	  3.5.1	   Verification	  of	  siRNA	  knockdown	  of	  Ets-­‐2	  in	  cell	  culture.	  ...................................................	  29	  3.5.2	   Effects	  of	  siRNA	  knockdown	  of	  Ets-­‐2	  on	  fiber	  type	  distribution	  in	  EDL.	  ......................	  30	  3.5.3	   Semi-­‐quantitative	  assessment	  of	  TnIf	  expression	  in	  Ets-­‐2	  siRNA	  transfected	  fibers	  in	  EDL.	  31	  	  
	  4	   Discussion	  .........................................................................................................	  32	  
4.1	   Expression	  patterns	  of	  Troponin	  I	  ........................................................................................	  32	  
4.2	   Trans	  activating	  abilities	  of	  Ets2	  in	  slow	  fibers.	  ...............................................................	  33	  
4.3	   Knockdown	  of	  Ets-­‐2	  in	  EDL	  ......................................................................................................	  34	  
4.4	   Future	  prospects	  .........................................................................................................................	  34	  
4.5	   Conclusions	  ...................................................................................................................................	  35	  
5	   Appendices	  ........................................................................................................	  36	  
5.1	   DNA	  electroporation	  solutions	  ...............................................................................................	  36	  5.1.1	   pEts-­‐2	  and	  pAP-­‐LacZ	  solution	  (200	  µl)	  ........................................................................................	  36	  5.1.2	   pSHAM	  and	  pAP-­‐LacZ	  solution	  (200	  µl)	  ......................................................................................	  36	  5.1.3	   RNAi	  vector	  and	  pAP-­‐LacZ	  solution	  (200	  µl)	  .............................................................................	  36	  
5.2	   siRNA	  inserts	  ................................................................................................................................	  36	  
5.3	   Cell	  culture	  ....................................................................................................................................	  37	  5.3.1	   Cell	  lysis	  buffer	  ........................................................................................................................................	  37	  5.3.2	   10%	  FCS	  DMEM	  (Dulbecco's	  Modified	  Eagle	  Medium)	  ........................................................	  37	  
5.4	   Western	  blotting	  .........................................................................................................................	  37	  5.4.1	   10X	  transfer	  buffer	  solution	  ..............................................................................................................	  37	  5.4.2	   10X	  TBS	  solution	  (Tris-­‐buffer	  saline)	  and	  TBS-­‐T	  ....................................................................	  37	  
5.5	   Histochemistry	  ............................................................................................................................	  38	  5.5.1	   10X	  PBS	  (phosphate-­‐buffered	  saline)	  solution	  .........................................................................	  38	  5.5.2	   Staining	  for	  MyHC	  isoforms	  ..............................................................................................................	  38	  5.5.3	   Staining	  for	  Troponin	  isoforms	  .......................................................................................................	  39	  5.5.4	   Staining	  for	  β-­‐galactosidase	  activity	  ..............................................................................................	  40	  
6	   References	  .........................................................................................................	  41	  
 
 
 
 
 	  
2	  
1 Introduction 
 
1.1 Fiber types 
Since the middle of the 19th century scientists have distinguished skeletal muscles on the basis 
of their color and contractile properties (Ranvier, 1873). Based on these distinctions, two 
model muscles, one on each side of the spectrum has been established; The fast extensor 
digitorum longus (EDL) is described as a typical white and soleus as a typical red and slow 
contracting muscle (Lee, 1916). 
 
Within the last 40 years our knowledge about muscle and muscle fiber diversity has rapidly 
expanded. Early work on the dynamic properties of muscle was based on the assumption that 
they were made up of a uniform population of fibers with similar mechanical properties. 
Modern classification arose with the identification of three distinct motor units, characterized 
by fiber type populations with different isometric contraction speed (Close, 1967). With the 
notion that fibers within the same motor unit were constrained to the same pattern of enzymatic 
activity, the correlation between fatigue resistance, twitch-speed and oxidative capacity was 
recognized (Edstrom and Kugelberg, 1968; Barnard et al., 1971). 
 
The functional relationship between mechanical and biochemical properties was established in 
1967, when Barany et al. (1967) provided evidence for the linear relationship between 
shortening velocity and the muscles’ ability to hydrolyze adenosine triphosphate (ATP) via its 
myosin ATPase domain (mATPase). The same histochemical approach on serial sections led to 
the establishment of three main fiber types, designated type 1, type 2a, and type 2b (Brooke 
and Kaiser, 1970). The variations in mATPase activity was later shown to correlate with the 
expression of a specific myosin heavy chain (MyHC) isoforms (Reiser et al., 1985). With the 
subsequent development of immunohistochemical techniques and monoclonal antibodies, a 
fourth rodent MyHC isoform, 2x, was discovered (Schiaffino et al., 1989). According to its 
phenotypic features, this fiber was classified as an intermediate between 2a and 2b. This led to 
the current classification of skeletal muscle fibers, based on their individual expression of 
MyHC isoforms (Spangenburg and Booth, 2003). 
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Fibers expressing MyHC1 are commonly referred to as slow-twitch, or type 1 fibers. Being 
rich in myoglobin and oxidative enzymes, this sub-group of fibers produces ATP by oxidative 
phosphorylation, ensuring a steady supply of ATP for prolonged activity, hence their relative 
abundance in postural muscles (Schiaffino and Reggiani, 2011). Fibers expressing MyHC 2a, 
2x, and 2b are commonly referred to as fast-twitch fibers. In the listed order they show an 
increased contraction speed, accompanied by a decrease in their mitochondrial content (Ingjer, 
1979). As a result, fast-twitch fibers contain less oxidative enzymes and rely on anaerobic 
glycolysis for their ATP production. Some of the properties of different fiber types are listed in 
table 1.1. 
 
Table 1. Overview of MyHC expression and physical properties of different fiber types in skeletal muscles 
of adult rodents 
Fiber	  type:	   MyHC	  isoform:	   Shortening	  velocity:	   Metabolic	  profile:	   Endurance:	  
I MyHC 1 Slow Oxidative Good 
IIa MyHC 2a Fast Oxidative-glycolytic Good-medium 
IIx MyHC 2x Faster Glycolytic-oxidative Medium-poor 
IIb MyHC 2b Fastest Glycolytic Poor 
Fiber type is classified according to MyHC expression, which is a major determinant of the shortening velocity. 
The metabolic profile reflects the endurance. 
 
Twitch speed, i.e., the time course of tension development and decline in response to a single 
electrical stimulus, is not only dependent on the expression of a specific MyHC isoform, but is 
strongly related to expression of fiber type specific proteins involved in handling Ca2+ kinetics. 
Such proteins include Sarco/Endoplasmatic reticulum Ca2+ ATPase (SERCA) and the different 
subunits of the troponin complex (Tn). During muscle relaxation the active calcium transport 
mechanism into Sarcoplamatic Reticulum (SR) is based on SERCA pumps (Gundersen et al., 
1988). In adult rodents there are two main isoforms expressed; SERCA1 is predominantly 
expressed in fast muscle fibers and SERCA2 in slow skeletal muscle, cardiac muscle, and 
smooth muscle (Periasamy, 2007). The activity of SERCA1 is greater than SERCA2, providing 
a faster uptake of calcium and faster relaxation time. Differential expression of subunits of the 
troponin complex affects the fibers’ sensitivity towards Ca2+ (Perry, 1998) (further explained in 
section 1.4). 
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1.2 Plasticity of fiber type 
Although adult skeletal muscle is composed of fully differentiated cells, they are highly 
susceptible to phenotypic alterations. Transition of phenotype is observed during aging 
(Larsson and Ansved, 1995), physical exercise (Thompson, 1994), hormonal influence (d'Albis 
et al., 1990) or experimentally by artificial stimulation of motorneurons or the muscle directly 
(Vrbova, 1963; Gundersen, 1985). This phenotypic plasticity is a result of the coordinated 
activation/repression of genes encoding different isoforms of contractile and metabolic proteins 
(Schiaffino and Reggiani, 1996). Changes in the pattern of neural influence are shown to have 
the most profound effect on phenotypic gene expression (Pette and Vrbova, 1985). This has 
been demonstrated in a series of classical cross-innervation studies were the fast EDL becomes 
slow when innervated by a “slow-nerve”, similarly, the slow soleus adopt fast-twitch properties 
when innervated by a “fast-nerve” (Buller et al., 1960; Close, 1965). How the nerve managed 
to conduct these changes was elucidated by artificial stimulation of denervated soleus with a 
fast frequency pattern mimicking endogenous nerve activity (Lomo et al., 1974). This 
demonstrated that the electrical signal alone is sufficient to induce transformation in 
phenotype. Generally, slow-twitch motor units receive a high amount of impulses in low-
frequency trains, while fast-twitch motor units seems to receive short bursts of high-frequent 
activity (Hennig and Lomo, 1985). The amount of activity seems to be important for the 
regulation of MyHC (Gundersen and Eken, 1992), while the frequency patterns seem to be 
important in determining the twitch duration (Westgaard and Lomo, 1988). 
 
Denervation (interruption of the nerve connection) causes a gradual loss in fiber specificity; 
slow muscles become faster and fast muscles become slower (Gutmann et al., 1972; 
Gundersen, 1985; Schiaffino et al., 1988). Transitions of fiber type tend to follow a sequential 
and reversible scheme, from fast to slow and slow to fast: 1↔2a ↔2x ↔2b (Windisch et al., 
1998). During transitional stages, hybrid fibers expressing two or more MyHC isoforms are 
common (Pette & Staron, 2000). 
 
Muscle inactivity or decreased activity is associated with a shift of MyHC expression in a fast 
direction, accompanied by a reduction in fiber cross-sectional area (atrophy) (Gardetto et al., 
1989; Pette and Staron, 2000). Endurance training is characterized by prolonged low-frequency 
activity, associated with an increase in the oxidative capacity of the muscle (Dudley et al., 
1982; Carter, 2001). Depending on the duration and intensity, endurance training has been 
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reported to induce fast to slow MyHC transition (Sullivan et al., 1995; Allen et al., 2001). 
Resistance training is characterized by phasic high-frequency activity, commonly associated 
with an increase in fiber cross-sectional area (McCall and Byrnes, 1996). 
 
In rodents, skeletal muscles are still immature after birth. Several important changes take place 
during the postnatal development, such as the elimination of the polyneuronal innervation 
(Brown et al., 1976), disappearance of embryonic and neonatal MyHC-isoforms (Schiaffino et 
al., 1988) and up-regulation of fast MyHC isoforms in prospective fast fibers (Russell et al., 
1988; DeNardi et al., 1993). In rat soleus, an increase in the proportion of type I fibers is 
observed during postnatal development, a progress that continues throughout adulthood 
(Kugelberg, 1976). As the animal gets older, a progressive decline in shortening velocity is 
observed in EDL and the opposite is noted in soleus (Close, 1964). 
 
Another factor involved in fiber type differentiation is the circulating level of thyroid 
hormones, which is low after birth and increase during postnatal-development until it reaches 
its maximum value at three weeks after birth (Gambke et al., 1983). Thyroid hormones have 
been implicated in the induction of fast MyHC expression during postnatal development. The 
transition from neonatal to adult MyHC is accelerated by hyperthyroidism and decelerated by 
hypothyroidism (d'Albis et al., 1990). The effect of thyroid hormone seems to be independent 
of the nerve, as daily injections of thyroid hormone in newborn rats causes a precocious 
increase in fast MyHC mRNA (Russell et al., 1988). 
 
1.3 Signaling pathways regulating muscle plasticity 
In eukaryotic cells, gene expression is mainly regulated at the level of transcription (Alberts et 
al., 2008). Cis-acting elements are short DNA sequences in the vicinity of the core-promoter, 
containing DNA consensus sequences that bind specific proteins (trans-acting factors), that can 
either repress or promote transcription (Buchwalter et al., 2004). As mentioned in the last 
section, the nerve is an important mediator of gene expression. How the nerve manages to 
conduct these changes is less clear. A reasonable assumption may be that there are some 
sensors that register the signal, which in turn activate/repress trans-acting factors resulting in 
phenotypic alterations. 
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In muscles, a lot of attention has been paid to the regulatory mechanisms of the calcium 
binding protein calmodulin (CaM). CaM has the ability to decode information carried by Ca2+ 
transients through activating a set of downstream proteins, including the calcium-dependent 
phosphatase calcineurin (Cn) and the calmodulin-dependent protein kinase (CaMK). CaM 
activates its substrates by allosteric regulation (Walsh, 1983). During the slow tonic-activity 
associated with slow-twitch fibers, sustained elevations in [Ca2+]i facilitate the binding of CaM 
to Cn (Crabtree and Olson, 2002).  Upon activation, Cn dephosphorylates multiple substrates; 
among them the nuclear factor of activated T-Cells (NFAT). Dephosphorylated NFAT 
translocates to the nucleus where it forms complexes with other transcription factors and 
participates in regulation of calcium-responsive target genes (Rao et al., 1997). In vivo 
overexpression of constitutively active NFATc1 in denervated EDL has been shown to induce 
the expression of MyHC I (McCullagh et al., 2004). Injections of Cyclosporine A, an inhibitor 
of Cn; has shown to increase the amount of fast MyHC isoforms in adult soleus (Chin et al., 
1998). These findings demonstrate the importance of NFAT in the maintenance of a slow 
phenotype. 
 
The transcriptional activity of NFAT is known to require the help of other transcription factors, 
among them the myocyte enhancer factor 2 (MEF2) (Wu et al., 2000). MEF2 cis-elements are 
found in promoters/enhancers of a number of muscle specific genes (Blaeser et al., 2000). 
Transgenic mice harboring MEF2 reporter constructs show that MEF2 activity is high during 
development and after endurance training (Wu et al., 2001). Treatment with Cyclosporine A 
results in decreased MEF2 reporter activity, suggesting that MEF2 is under the control of Cn 
(Wu et al., 2000). Several studies have demonstrated that MEF2 activity is controlled through 
association with class II Histone deacetylases (HDACs) (Lu et al., 2000; McKinsey et al., 
2000), which bind and repress expression of MEF2-dependent genes by promoting the 
formation of heterochromatin (McKinsey et al., 2000). In vitro studies have shown that 
signaling by CaMK results in phosphorylation of class II HDACs, promoting shuttling of 
HDACs from the nucleus to the cytoplasm resulting in activation of MEF2-responsive genes 
(Lu et al., 2000). 
 
Differential expression of the myogenic regulatory factors (MRFs), MyoD and myogenin, 
provides a possible link between phenotype and electrical activity (Ekmark et al., 2003). Being 
expressed in fast- and slow-fibers respectively; slow-patterned stimulation of denervated EDL 
result in an increased expression of myogenin (Hughes et al., 1993). Cross-innervation of a 
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fast-nerve to soleus results in increased MyoD expression followed by increased expression of 
MyHC 2 isoforms (Ekmark et al., 2007). MyoD is under the regulation of post-translational 
modification. Overexpression in denervated soleus results in slow-to-fast transition (Ekmark et 
al., 2007). When being overexpressed in innervated soleus no significant change is observed, 
due to the presence of a phosphorylated threonine (T115), which inhibits the transactivating 
ability of MyoD (Ekmark et al., 2007). 
 
1.4 The troponin complex 
The troponin complex (Tn) is at the center of Ca2+ mediated muscle contraction. Being located 
in the groove between the thin and thick filaments it prevents muscle contraction by inhibiting 
the initiation of the cross bridge cycle. In a relaxed muscle, the Tn associated protein 
tropomyosin (Tm) blocks the attachment-site for myosin on actin. Following depolarization, 
elevation in Ca2+ causes conformational changes in the complex that moves Tm out of the way, 
exposing the binding site on actin. Being a heteromeric protein, Tn is composed of three 
different subunits - Troponin T (TnT), Troponin C (TnC) and Troponin I (TnI).  
 
TnT is the largest subunit of Tn, and derives its name based on its ability to form specific 
interactions with tropomyosin (Cabral-Lilly et al., 1997). It is the largest subunit of the 
complex, and is of particular importance in the structural positioning and stability of Tn along 
the myofibrils (Perry, 1998).  In the mammalian genome, TnT has diverged into three isoforms 
corresponding to the cardiac, slow- and fast-skeletal fiber types (Schiaffino & Reggiani, 1996).  
 
TnC is the subunit responsible of binding calcium and has diverged into two separate isoforms, 
each with a different sensitivity towards Ca2+ (Parmacek and Leiden, 1989). One isoform is 
expressed in fast skeletal muscle fibers and another in cardiac and slow skeletal fibers 
(Parmacek and Leiden, 1989). The differential sensitivity towards Ca2+ is related to the 
existence of a high affinity-binding site in the cardiac/slow isoform, whereas the TnC of fast 
fibers has two high affinity binding sites. As a result, slow fibers develop tension at lower 
[Ca2+]i than fast fibers (Genchev et al., 2013). 
 
TnI occupies a central position in the control of the contractile apparatus, where it acts as a link 
between Tn and myosin (Perry, 1999). Conformational changes resulting from the binding of 
calcium to TnC are conveyed through TnI to the mATPase domain of myosin where it 
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regulates sensitization of mATPase (Farah et al., 1994).  In vitro studies using purified TnI 
have shown TnI-facilitated mATPase inhibition in the absence of Tm (Perry, 1998).  In 
mammalian skeletal muscle two TnI isoforms are present, corresponding to fast and slow fiber-
types (Hallauer et al., 1988). Interestingly, the expression of a respective TnI isoform is always 
coupled to the expression of the corresponding fast-/slow-twitch TnT isoform, suggesting a 
rather tight transcriptional regulation (Brotto et al., 2006). 
 
1.5 Transcriptional regulation of the Troponin I genes 
Studies investigating the transcriptional regulation of the troponin I genes were initially 
performed in cell culture, where the transcriptional regulation of rat troponin I slow (TnIs) and 
quail Troponin I fast (TnIf) could be analyzed during myoblast differentiation (Konieczny and 
Emerson, 1987; Banerjee-Basu and Buonanno, 1993). By using reporter constructs it was 
demonstrated that the 5´ flanking segments of the TnIf gene could be removed without having 
any notable effect on the normal expression pattern (Konieczny and Emerson, 1987). Instead, it 
was demonstrated that the developmental-specific transcription of TnIf is dependent upon an 
internal regulatory element (IRE) confined to the first intron (Yutzey et al., 1989). 
Transcriptional activation of TnIs was delineated using reporter constructs containing the 
5´flanking sequence of TnIs, showing that the 200bp upstream of the translation initiation site 
was sufficient to confer the differentiation-specific expression associated with TnIs (Banerjee-
Basu and Buonanno, 1993). Subsequent studies performing systematic deletions within the 
Intronic and the upstream elements led to the identification of the 144 bp Fast Intronic 
Regulatory Element (FIRE) and the 128 bp Slow Upstream Regulatory Element (SURE) 
(Nakayama et al., 1996). These elements contain series of regulatory cis-elements conferring 
general muscle and fiber specific expression (Calvo et al., 1996; Nakayama et al., 1996; Calvo 
et al., 1999). The relative order of the cis-acting elements is highly conserved (Fig. 1), and the 
interactions between the different trans-acting factors may therefore be important in 
determining the phenotypic outcome. 
 
Figure 1. Regulatory elements in the Slow Upstream Regulatory Element (SURE) and the Fast Intronic 
Regulatory Element (FIRE). Simplified figure representing conserved sequence blocks conferring general 
muscle specificity (yellow) and cis-elements accountable for fiber specific expression (blue). Indicated by arrows 
are the target recognition sequences for trans-acting factors, which under the right circumstances may bind and 
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facilitate transcription/repression of the genes. The relative order of the cis-acting elements is highly conserved; 
interactions between various trans-acting factors may therefore be important in determining the phenotypic 
outcome. The figure is based upon data from (Hallauer et al., 1988; Yutzey et al., 1989; Banerjee-Basu and 
Buonanno, 1993; Calvo et al., 1996; Nakayama et al., 1996; Calvo et al., 1999; Calvo et al., 2001; Rana. et al., 
2008; Rana. et al., 2011). 
 
The functional influence of NFAT on TnI expression is diverse, with NFAT binding sites 
found in both SURE and FIRE (Fig. 1). In vitro studies show SURE activation in response to 
constitutively active Cn. By mutating the NFAT-element the effect was eliminated (Wu et al., 
2000).  NFAT has been proven necessary to inhibit FIRE expression during slow patterned 
activity (Rana. et al., 2008). siRNA mediated knockdown of NFATc1 and introduction of 
mutations in the NFAT binding-site have both shown to activate FIRE expression in adult 
soleus, without affecting the fast enhancer activity in EDL (Rana. et al., 2008). Together, these 
findings suggest a dual mechanism for transcriptional enhancement, where NFATc1 acts as a 
transcriptional activator and repressor in slow and fast-twitch fibers, respectively. 
 
MEF2 is necessary for transcriptional activation of both TnI enhancers (Nakayama et al., 1996; 
Calvo et al., 1999). In vitro overexpression of Cn shows selective upregulation of reporter 
constructs harboring SURE (Wu et al., 2000), and when the SURE MEF2 consensus is mutated 
into the corresponding FIRE consensus (Fig. 1) the effect is abolished (Wu et al., 2000). In the 
same study it was demonstrated that the FIRE consensus provides a weaker binding site for 
MEF2, suggesting that MEF2 binds synergistically with NFAT in the activation of the SURE 
enhancer (Chin et al., 1998). 
 
The general transcription factor 3 (GTF3) binds specifically to a bicoid like motif in the 
upstream region of SURE and represses activation of TnIs in developing and regenerating 
fibers (Calvo et al., 1999). During fetal development, the loss of TnIs expression in prospective 
fast fibers is associated with a period of high GTF3 expression (Vullhorst and Buonanno, 
2003). In vivo overexpression of GTF3 has been shown to reduce transcriptional activation of 
reporter constructs harboring SURE, implicating GTF3 potential role in maintenance of 
phenotype in fast-twitch fibers (Calvo et al., 2001). 
 
MRFs bind the E-box sequences found in the two TnI enhancers (Yutzey and Konieczny, 
1992). Introductions of mutations (Calvo et al., 1999) or removal of the E-box sequence 
(Nakayama et al., 1996) abolishes the transcriptional activity of both elements. Since MRFs are 
known to form complexes with other trans-acting factors, including MEF2 (Molkentin et al., 
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1995), they are believed to provide a scaffold for the recruitment and assembly of 
transcriptional complexes at the core promoter (Londhe and Davie, 2011). Trans-acting factors 
targeting the CAGG-box have not yet been identified, although their presence is essential for 
SURE and FIRE activation (Calvo et al., 1996; Calvo et al., 1999). In similar manner, the 
CACC-box, which binds SP-1 is necessary for activation of both enhancers (Bassel-Duby et 
al., 1994; Nakayama et al., 1996). An interaction between SP-1, myogenin and MEF2 is 
required for the activation of the cardiac actin gene (Biesiada et al., 1999), indicating that the 
formation of a multi-protein transcriptional complex and interaction between various 
transcription factors might be an important mechanism in the regulation of TnI. 
 
In rodents, expression of TnI proceeds in two distinct stages according to the fetal and post-
natal expression pattern. During fetal development, there is no confined expression pattern 
towards either fiber type, with TnIs and TnIf transcripts being widely expressed in all fibers 
(Calvo et al., 2001). As development continues, the uniform distribution segregates into 
prospective slow and fast fibers. Following birth, expression is highly upregulated in a 
motorneuron dependent fashion where TnIs and TnIf transcripts are confined to either slow- or 
fast-twitch fibers, respectively (Fig. 2) (Koppe et al., 1989; Calvo et al., 1996). Denervation 
causes a decrease in fiber-type specific transcription, resulting in expression levels similar to 
postnatal values (Rana et al., 2005). At protein level this expression is reflected as an increase 
in the population of hybrid fibers (Dhoot and Perry, 1981). 
 
 
Figure 2. Model representing the regulation of Troponin I fast in maturing fast (blue) and slow (red) 
muscle fibers. The relative expression of TnIf varies during development and may be divided into three different 
stages according to the embryonic, postnatal and adult expression pattern. During prenatal development the 
expression is broad with no confined expression to either fiber type. After birth, emergence of patterned activity 
separates TnI expression into prospective fibers. (3) In fully developed fibers, trans-acting factors repress and 
maintain expression fast isoform in fast fibers and vice versa for slow fibers. This panel is from Rana. et al., 
(2008). 
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1.6 Ets Family of transcription Factors 
The founding member of the Ets family, v-ets was first discovered as a fusion protein being 
expressed by the avian retrovirus E26 capable of inducing leukemia in infected chickens 
(Leprince et al., 1983). Cloning of cellular homologues (Watson et al., 1985) and through the 
observations that they were binding to similar DNA sequences, led to the establishment of ets-
proteins as a new family of eukaryotic transcription factors (Karim et al., 1990). To date, at 
least 26 members have been identified in humans (Shaikhibrahim and Wernert, 2012) with 
family members ranging from primitive metazoans to mammals (Degnan et al., 1993) The 
common feature of the family is their highly conserved DNA binding domain, which binds to 
the purine rich sequence GGAA/T found in the promoter of multiple genes (Fig. 1) (Sharrocks 
et al., 1997). Most Ets-domain proteins are targets of signal transduction pathways and are 
directed to promoters through specific DNA-protein and protein-protein interactions (Wasylyk 
et al., 1998; Jayaraman et al., 1999). Ets proteins have been implicated in an array of different 
cellular functions and have roles in development, transformation and cellular proliferation 
(Maroulakou and Bowe, 2000; Oikawa and Yamada, 2003). 
 
1.7 Ets-2 
Although its function in human skeletal muscle is poorly understood, Ets-2 has been an intense 
field of study due to its high expression in a number of human malignancies (Galang et al., 
2004; Seth and Watson, 2005; Xu et al., 2008). The ETS-domain of Ets-2 is located at its C-
terminus, and the N-terminal portion of the protein contains two transactivation domains and a 
highly conserved pointed (PNT) domain (Wasylyk et al., 1998). Post-translational modification 
of the PNT-domain directly affects its function and subcellular compartmentalization (Foulds 
et al., 2004). In myoblasts, overexpression of Ets-2 increase the expression of Ctpr5 (Park and 
Kim, 2012), a protein involved in translocation of the glucose transporter 4 (GLUT4) and 
activator of AMP kinase. This proposes a putative involvement in regulation of glucose uptake 
and fatty acid oxidation (Lee et al., 2010). Ets-2 is a target of the MAP kinase pathway and 
CaMKII (Foulds et al., 2004; Yu et al., 2009), and is shown to couple extracellular signals to 
transcriptional response (Okamura et al., 2009) Binding of Ets-2 to the canonical (5´-GGAA-
3´) binding site in the FIRE enhancer has recently been demonstrated by using electrophoretic 
mobility shift assay (EMSA) (Rana. et al., 2011) This binding site is located between the SP1 
and MEF2 elements, factors which are known to form ternary complexes with Ets-domain 
proteins (Buchwalter et al., 2004). Microarray profiling has revealed selective upregulation in 
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denervated soleus when stimulated with fast patterned activity (Rana. et al., 2011). High 
frequency stimulation of denervated muscles transfected with GFP-tagged Ets-2 show an 
increase in the nuclear/cytoplasmic ratio of Ets-2 (Rana. et al., 2011), indicating that fast-
patterned electrical activity may be an important mechanism for maintenance of nuclear Ets-2 
in fast fibers (Fig. 2). Like NFATc1, that can either stimulate (Chin et al., 1998) or repress 
(Rana. et al., 2008) the activity of TnIs, Ets-2 might represent an equally important factor in 
maintaining a fast phenotype. The fact that Ets-2 accumulates in the nuclei in response to 
patterned activity allows for a dynamic regulation of its target genes. 
 
 
Figure 3. Nuclear shuttling of Ets-2. (A) Image is showing the intensity projections in unstimulated muscles 
transfected with a vector encoding GFP tagged Ets-2. In EDL Ets-2-eGFP selectively accumulates in the nucleus 
in response to fast patterned activity. In soleus, Ets-2-eGFP is uniformly distributed between nucleus and cytosol. 
Hoechst dye (blue) marks all nuclei (Bars= 20µm). B) Quantification of nuclear/cytoplasmic fluorescence 
intensity ratios. Each point represents the average of 3-10 nuclei/fiber from 8 rats. Graph shows that there is a 
significant accumulation of Ets2-eGFP in fast fibers of EDL. This figure is from Rana et al., 2009. 
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1.8 Aims of the study 
What is the normal distribution of Troponin I isoforms in EDL and soleus? 
To answer this question, normal muscles were excised, sectioned and stained for MyHC and 
TnI isoforms. 
 
Will overexpression of Ets-2 change the phenotypic composition of adult soleus in a fast 
direction? 
To answer this question, an expression vector encoding Ets-2 was transfected into adult muscle 
fibers of rat soleus. MyHC and TnI isoform expression in transfected fibers was analyzed after 
fourteen days and compared to normal non-transfected and sham transfected fibers. 
 
Will knockdown of Ets-2 change the phenotypic composition of EDL in a slow direction? 
To address this question, siRNAs targeting Ets-2 were transfected into muscle fibers of adult 
rat EDL. MyHC isoform distribution and TnI expression were analyzed and compared against 
fibers transfected with a scrambled siRNA sequence and normal control fibers.  
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2 Materials and Methods 
 
2.1 Overview 
In the first part of the study, the normal fiber type specific expression pattern of TnI in adult 
rats was determined. Untreated EDL and soleus muscles from 16 weeks old animals were 
sectioned and histochemically stained for TnI- and MyHC isoform expression. 
 
In the second part of this study, soleus muscles of 10 adult rats were transfected with three 
plasmids; one expression vector encoding wild type Ets-2 (pEts-2), one sham control (pSham) 
and one plasmid encoding the reporter protein β-galactosidase (pLacZ), which were used to 
identify transfected fibers. The right soleus was transfected with pEts-2 and pLacZ and served 
as the experimental leg, while the left soleus was transfected with pSham and pLacZ, serving 
as a sham control. The transfer of DNA into the fibers was facilitated by in vivo 
electroporation. Fourteen days after surgery animals were anesthetized and muscles were 
removed and frozen in liquid isopentane (-160°C). Muscles were stored at -80°C and were later 
cryosectioned and histochemically stained for β-galactosidase activity. Fiber types from the 
different experimental groups were determined using various monoclonal antibodies against 
MyHC, and polyclonal antibodies against the troponin I isoforms.  
 
In the third part of the study, EDL muscles of 12 adult rats were transfected with RNAi 
expression vectors encoding siRNA against Ets-2. The rats were divided into two groups; each 
group consisting of six rats transfected with a siRNA targeting different sites at the Ets-2 
mRNA. In both groups the right leg served as experimental and the left as a sham control. All 
muscles were co-transfected with pLacZ. The procedures for analysis follow the same regime 
as the overexpression part of the study. 
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2.2 Animal experiments 
2.2.1 Animals  
All animal experiments were approved by the Norwegian Research Authority, and conducted 
in accordance to the Norwegian Animal Welfare Act of December 20th, 1974, no.37, chapter 
VI sections 20-22, and the Regulation of Animal Experimentation of January 15th 1996. The 
animal experiments were performed on 14 weeks old male Wistar rats, kept in the animal 
facility at Kristine Bonnevies Hus, University of Oslo. Groups of four to five animals were 
kept in cages in rooms regulated with a constant temperature of 22°C, air humidity at 50-60% 
and with regulated light cycles at 12h/12h intervals. Food and water were given ad libitum. 
 
2.2.2 Anesthesia 
Preceding surgical procedures, each animal was anesthetized with 2.0-2.5% isoflurane gas 
(506949, Forene, Abbot) with airflow of 500-700cc/min. The degree of anesthetization was 
determined by pinching the metatarsus region of the foot while observing the withdrawal reflex 
of the leg. Absence of reflex confirms that the animal is in deep anesthesia. Further anesthetics 
were administered if necessary. 
 
2.2.3 Surgical procedures 
When deep anesthesia was induced, hair from the leg was removed with an electric shaver 
followed by application of hair removal cream (Veet). EDL was surgically exposed by making 
an incision of 1cm at the lateral side of the leg; the distal tendon of EDL lies parallel with the 
distal tendon of Tibialis Anterior, which is easily identified as it lies on the lateral side of Tibia. 
Soleus was exposed by making an incision along the soleal line, a prominent ridge at the 
posterior side of tibia. During surgery the muscle and the surrounding area were continuously 
kept wet by applying ringer-acetate solution (131323, B. Braun Petzold). Following 
electroporation (below) the wound was closed with sutures (Softsilk, S-1172, 12 mm, 
Syneture). 
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2.2.4 In vivo electroporation 
Uptake of plasmid DNA by electroporation/electropermeabilization is though to be facilitated 
by two separate events; permeabilization of the cell by the formation of small pores in the 
plasma membrane, and by electrophoresis that moves DNA into the cell (Somiari et al., 2000; 
Lu et al., 2003). There are several factors determining transfection efficiency, one of them 
being the quality of transfected DNA. DNA isolated with commercially available kits may 
contain large amounts of endotoxins, which have to be removed to avoid undesired 
inflammatory responses. Therefore, all vectors used in this study were purified by an endotoxin 
removal step and by isolation in a CsCl gradient (Engebrecht et al., 2001). Pulse pattern and 
field strength contributes to overcome the trans-membrane threshold of the fiber, with 
increasing diameter, a higher field strength is required to reach the trans membrane threshold 
(Lu et al., 2003).  
 
In vivo transfection/electropermeabilization of plasmid DNA was performed as described by 
Mathiesen (1999). Following surgical exposure, an insulin syringe (0.3ml, BD Micro-Fine™, 
VWR) was used to inject 50µl of a 0.5µg/µl DNA solution (see appendix) into the belly of 
EDL or soleus. After injection, two silver electrodes (1cm long and 1mm thick) placed 2-3 mm 
apart were moved along the muscle. The electrical field was applied using a pulse generator 
(Pulsar 6bp, Fredrick Haer & Co). Five trains with 1 second intermission were applied over the 
muscle, each consisting of 1000 bipolar pulses with amplitude of 150V/cm, 200µs in each 
direction. The electrical charge was registered by an analogue oscilloscope (03245A, Gould 
Advance). 
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2.3 DNA constructs 
2.3.1 Ets-2 expression vector 
The vector used in this study was a kind gift from Professor H. Sugimoto (Dokkyo Medical 
University School of Medicine, Japan). It encodes an Ets-2 fusion protein covalently bound to 
enhanced green fluorescent protein (eGFP) (Fig. 4b). This vector has previously been used in 
studies concerning cytosolic-nuclear shuttling of Ets-2 (Okamura et al., 2009; Rana. et al., 
2011). In the present study the aim was to investigate Ets-2 as a transcriptional activator. 
Expression of eukaryotic genes relies on the assembly of a pre-initiation complex at the core 
promoter, and because eGFP might interrupt this process, the wild type protein was restored by 
conventional cloning. 
 
The full vector sequence was obtained by sequencing, (ABI 3730, high-throughput capillary 
electrophoresis sequencer). Sequences were aligned using Jalview V2 (Waterhouse et al., 
2009), and imported into CLC Genomic Workbench 6 for the identification of unique 
restriction sites and open reading frame (ORF) analysis. Using site-directed mutagenesis 
(Quick-change, Stratagene, CA, USA), the 5´ HindIII recognition site located between the 
eGFP and Ets-2 reading frame were changed to AgeI (Fig. 4c). The experimental vector, pEts-
2 (Fig. 4d) could now be generated by excision of eGFP via an AgeI restriction digest. The 
sham vector (pSHAM) (Fig 4e) was made by digesting pEts-2 with BamHI. ORF analysis was 
performed in CLC and all mutations were verified by sequence analysis. The vectors were 
transfected in human embryonic kidney (HEK-293) cells and western blots were run to verify 
protein expression (section 2.3.3). In addition, a reporter plasmid, pAP-lacZ (Fig. 4a), was used 
to identify transfected fibers. The 7.8 kb plasmid encodes β-galactosidase driven by a Rous 
sarcoma virus (RSV) (Mathiesen, 1999). This plasmid was a kind gift from Professor N. 
Gautam.  
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Figure 4. Expression vectors. (A) pAP-LacZ (gift from N. Gautam) with the Roussarcoma virus (RSV) promoter 
for enhanced expression of the LacZ gene in mammalian cells. A SV40 polyadenylation signals downstream of 
the LacZ gene direct proper processing of the 3' end of the LacZ mRNA. B) pEGFP-Ets2, a gift from professor 
Professor H. Sugimoto. Contained within the vector is a Cytomegalovirus (CMV) promoter for enhanced 
mammalian expression and a EGFP gene for identification of Ets-2. C) pEGFP-Ets2 after site directed 
mutagenesis, HindIII restriction site has been changed to AgeI. D) Experimental plasmid, Ets2 only, generated by 
excision of EGFP using AgeI restriction enzyme. E) Sham plasmid, generated by excision of Ets2 using BamHI. 
 
A 
B C 
D E 
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2.3.2 siRNA expression vectors 
During the last decade RNA interference (RNAi) has become an important tool in the field of 
functional genomics. Since its discovery, its ability to enable loss of function screens through 
degradation of specific mRNA molecules has shown to be a valuable resource in determining 
protein interaction and function (Moffat and Sabatini, 2006). 
 
GenScript is a commercial company, which provides siRNA vectors from submitted DNA 
sequences. Using a web-based computational algorithm an optimal target sequence is identified 
according to favorable thermo dynamical properties and GC-content, properties that affect the 
stability of the transcript. The program performs a BLAST search within the target organism to 
avoid overlap between endogenously produced mRNA transcripts and target siRNAs. By 
submitting the Ets-2 cDNA sequence from mouse (NM_011809.3) and rat (NM_001107107.1), 
two siRNA were predicted to knockdown expression of murine Ets2. The siRNAs sequences 
were cloned into a pRNA-CMV3.1/Neo expression vector allowing sustained expression of 
siRNA. Transcription of the siRNA gene is driven by a Cytomegalovirus promoter (CMV). An 
ampicillin resistance gene confined within the vector provides selection during transformation. 
In order to test desired knockdown of Ets-2, the RNAi vectors and Ets-2 expression vectors 
were co-transfected into HEK-293 cells and analyzed by western blotting. 
 
 
 
 
 
 
Figure 5. Mechanisms of RNA interference. An 
expression vector encoding the target sequence is 
electroporated into the cell. The primary 
transcript contains a hinge region followed by the 
reversed complimentary transcript, which 
facilitates formation of a hairpin loop. Presence of 
dsRNA activates Dicer, which cleaves the 
fragment into pieces of 18-24nt. Fragments are 
incorporated into the RNA induced silencing 
complex (RISC). One of the strands is degraded 
while the remaining strand facilitates recognition 
of target mRNA. Argonaute proteins confined 
within RISC catalyze cleavage of bound mRNA 
(Moffat and Sabatini, 2006). 
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2.4 Testing of DNA constructs 
2.4.1 Transfection in cell culture 
All expression vectors were transfected into HEK-293 cells. Cells were cultured in Dulbecco’s 
Modified Eagle Medium (DMEM) (GIBCO, Invitrogen, Raisley, PA49RF, United Kingdom) 
at 37°C in an atmosphere of 5% CO2. The cells were split every 4-5th day with trypsin EDTA 
1:4, dependent on the confluence. Transfection of pEts-2 and pSham was carried out in six well 
plates in accordance with the Lipofectamine™ 2000 kit (11668, Invitrogen). RNAi vectors and 
pEts-2 were co-transfected into HEK-293 cells according to the Lipofectamine™ 2000 
guidelines for co-transfection of RNAi and protein expression vectors (MAN0000995, 
Invitrogen). 
 
2.4.2 Protein isolation and measurements 
48 hours after transfection, the medium was removed and the cells put on ice before being 
washed twice in 1 ml cold PBS (70011-044, GIBCO). The cells were then lysed in 500 µl lysis 
buffer (see appendix). Cellular lysate was centrifuged at 13000 rpm for 20 minutes at 4°C. The 
supernatant was aliquoted and stored at -80°C until protein analysis. Protein concentration of 
cell lysates were measured according to the Bio-Rad Protein Assay Protocol (500-0006, Bio-
Rad) and read at 595nm by a micro plate reader (Victor2 1420, Perkin Elmer). 
 
2.4.3 Native PAGE and Western Blotting 
To verify relative protein expression, lysates from transfected cells were run on a gel and 
immunoblotted with an antibody against Ets-2 (Sc-22803, Santa-Cruz Biotechnology). Native 
polyacrylamide gel electrophoresis (Native PAGE) was performed according to the NuPAGE 
Technical Guide (IM-1001, Invitrogen Instruction Manual (2003)). The gels were run with 20 
µg protein sample on a 10 well NuPAGE® Novex 4-12% Bis-Tris Gels (NP0321, Invitrogen) 
at 150V. The size of the protein bands were determined using a protein ladder (See Blue Plus2 
Prestained Standard, LC5925, Invitrogen). Western blotting was performed according to the 
Trans-Blot Electrophoretic Transfer Cell Instruction Manual (170-3939, Bio-Rad). The gels 
were blotted onto PVDF membranes for 4 hours at 1000mA/50V. The membranes were 
blocked in 5% skimmed milk powder (70166, Fluka) in TBS-T (see appendix) for 1 hour at 
room temperature before applying primary and secondary antibodies. Antibodies (Table 2) 
were diluted in 5% skimmed milk powder solution in TBS-T, and incubated for 1 hour at room 
temperature. After incubation the membranes were washed for 10min in TBS-T and rinsed 
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with TBS (see appendix). To ensure even loading on the gels, staining with a mouse 
monoclonal anti-Vinculin antibody (V9131, Sigma-Aldrich), followed by ECL Peroxidase 
labeled anti-mouse antibody (NA931VS, Amersham) was performed. Immunostaining was 
followed by visualization on film (28906837, Amersham) using the ECL Western Blotting 
Analysis System (RPN2109, Amersham).  
Table 2. List of primary and secondary antibodies used in western blotting. 
Protein: Primary antibody: Concentration: Secondary: Concentration 
Ets-2 sc-22803, Santa-Cruz 1:1000 NA934V, Amersham 1:2000 
 Biotechnology  (anti-rabbit)  
Vinculin V9131, Sigma-Aldrich 1:40 000 NA931VS, Amersham 1:2000 
   (anti-mouse)  
 
2.5 Histochemistry 
2.5.1 Freezing of muscles 
After surgical removal, the muscles were slightly stretched between two pins on a home made 
form, and submerged in isopentane cooled to its freezing point (-160°C) with liquid nitrogen. 
The muscles were transferred to cryotubes (Microtube 2ml, PP, Sarstedt) and stored at -80°C 
until further processing. 
 
2.5.2 Preparation of muscle sections 
Muscles were cryosectioned in series of 10µm in a cryostat (CM1950, Leica Biosystems). 
During sectioning the sample held a temperature of -21°C and the knife -19°C. Serial sections 
from 10 - 12 muscles (right and left hind limb from the same animal) were placed on the same 
slide (Super-frost plus 2, Thermo Fisher), to achieve standardized conditions and exposure of 
all sections to near identical conditions during the following processing. 
 
2.5.3 Staining for β-galactosidase activity 
As previously mentioned, β-galactosidase was used as a reporter protein in the experiments to 
identify transfected fibers. The lacZ gene within pAP-LacZ encodes the enzyme β-
galactosidase that breaks down β-galactosides. One of its substrates is X-Gal (5-bromo-4-
chloro-3-indolyl-ß-D-galactoside), which is broken down to indoxyl and galactose. Two 
monomers of indoxyl dimereize to form an insoluble blue compound. Therefore, transfected 
fibers will appear blue (Mathiesen, 1999).  
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2.5.4 Staining for MyHC isoforms 
Monoclonal antibodies against MyHC-isoforms were used on serial sections to determine 
muscle fiber type. Secondary antibodies conjugated to FITC were used to visualize binding of 
the primary antibody to individual fibers (Table 3). When FITC is illuminated with blue-green 
light (488nm), it emits photons in the green region of the spectrum (495-519nm). 
 
Table 3. Primary and secondary antibodies for detection of MyHC isoforms 
 
 
	  	  
	  
	  
	  	  
	  
	  
	  	  
	  
	  
	  	  
	  
	  
	  	  
MyHC: Primary antibody: Secondary antibody: 
1 BA-D5 Rabbit Anti-mouse IgG FITC conjugated (F-9131, Sigma) 
2a SC-71 Rabbit Anti-mouse IgG FITC conjugated (F-9131, Sigma) 
2x 6H1 Goat Anti-mouse IgM FITC conjugated (F-9259, Sigma) 
2b BF-F3 Goat Anti-mouse IgM FITC conjugated (F-9259, Sigma) 
 
	  
 
Figure 6. Example of serial sections of an EDL muscle stained for myosin heavy chain and β-galactosidase 
activity. Serial cross sections stained for (A) β-galactosidase activity, (B) MyHC 1, (C) MyHC 2a, (D) MyHC 2x, 
and (E) MyHC 2b. Fibers stained for β-galactosidase appear blue (numbered 1-7 in yellow), while non-transfected 
normal fibers for control appear bright (numbered N1-N10). Positively stained fibers for the respective MyHC 
isoforms appear bright green, while negative fibers appear dark. Scale bar = 100µm. 
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2.5.5 Staining for Troponin I isoforms 
To determine the isoform-specific expression of troponin I, polyclonal antibodies against TnIf 
and TnIs were used on neighboring sections. Secondary antibodies conjugated to FITC or 
Alexa were used to visualize binding of the primary antibody.  
 
Table 4. Primary and secondary antibodies used for detection of troponin 
	  
	  
	  	  
	  
	  
	  	  
	  
	  
	  	  
Isoform: Primary antibody:  Secondary antibody: 
TnI fast Ab134838    Goat Anti-rabbit IgG FITC conjugated (T6778, Sigma)/ 
     Goat Anti-Rabbit IgG TRITC conjugated (F987, Sigma) 
TnI slow Ab97711    Donkey Anti-sheep, Alexa Fluor® 488 (A11015, Invitrogen) 
 
2.6 Imaging 
2.6.1 Bright-field imaging 
Bright field images of muscles stained for β-galactosidase activity were taken using a single-
lens camera (Canon 60D) connected to a microscope (BX50W1, Olympus). The sections were 
photographed with water immersion at 10x magnification. Images were imported into 
Photoshop CS6 for further processing. 
 
2.6.2 Fluorescent microscopy 
Serial sections stained with fluorophore conjugated secondary antibodies were photographed in 
a dark room with the same microscope setup as with bright-field imaging. A blue-green filter 
(XF22) was used to illuminate the sections with the FITC and Alexa Fluor® 488 conjugated 
secondary antibody; while a green filter (XF53) was used to illuminate the sections with 
TRITC conjugated antibodies. Further processing was performed as with bright-field imaging. 
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2.6.3 Quantification of TnIf expression 
TnIf expression was measured in muscle fibers transfected with siRNA, scrambled sequences 
and in randomly selected normal fibers within the same area. High-resolution images (40x) 
were captured of transfected fibers. Images was converted to 8bit, where the gray value is 
presented on a scale ranging for 0 (black) to 255 (white). TnIf intensity was quantified by the 
measurement of grey tone of manually encircled muscle fibers in ImageJ 1.46 (NIH, USA). In 
order to correct for photo bleaching, the mean gray value of normal MyHC IIb fibers in the 
same image was set to 1, and intensity of other fibers was normalized in relation to this value. 
The intensity of analyzed fibers was thus presented as a relative value in order to account for 
the potential differences in staining or bleaching of individual sections. 
 
2.7  Statistical procedures 
The films of the western blots were scanned and the band intensities measured with ImageJ 
1.46 (NIH, USA). For statistical comparison of the relative protein expression (i.e. band 
intensities) in gels loaded with cell-lysate from the siRNA experiment, a one-way ANOVA 
with a Newman-Keuls post-test was performed. The level of significance was set to 0.05. For 
statistical comparison of fiber type distribution a Chi-square test was performed. The level of 
significance was set to 0.05. For statistical comparison of the fluorescence intensity 
measurements, a one-way ANOVA with a Newman-Keuls post-test was performed. The level 
of significance was set to 0.05. All statistical calculations were done in GraphPad Prism 6. 
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3 Results 
 
3.1 Qualitative assessment of TnI expression. 
Histochemical staining for Troponin I isoforms was performed on muscle cross-sections from 
normal non-treated rats in order to visualize potential differences in the expression patterns 
between the typical slow leg muscle, soleus, and the typical fast leg muscle, EDL. Expression 
patterns of TnI were compared to MyHC expression by histochemical staining of serial cross 
sections to determine whether the fibrillar expression of fast and slow TnI correlates with the 
expression patterns of fast and slow MyHC, respectively.  
 
3.1.1 TnI expression pattern in EDL. 
In EDL (Fig. 7), TnIs expression is restricted to MyHC 1 positive fibers. Expression of TnIf 
was confined to fibers expressing MyHC 2. These findings show that TnI expression in EDL 
follows the “normal” pattern, with TnIs confined to slow-twitch muscles and TnIf to fast-
twitch fibers (Perry, 1999).  
 
 
Figure 7. TnI and MyHC isoform expression in normal EDL. Serial cross sections stained with antibodies 
against (A) TnIs, (B) TnIf, (C) MyHC 1, (D) MyHC 2a, (E) MyHC 2x, and (F) MyHC 2b. The findings indicate 
that TnI follows the “normal” expression pattern in EDL, were TnIs are being expressed in MyHC 1 positive 
fibers and TnIf in fibers positive for type 2 MyHC. Examples of a MyHC 1 and 2a positive fiber are denoted as 
(1.) and (2.), respectively. Negative control sections stained only with secondary antibodies gave no fluorescence 
for any of the antibodies used (data not shown). Scale bar = 100µm. 
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3.1.2 TnI expression in hybrid fibers of EDL. 
Hybrid MyHC 1/2a fibers in EDL express both TnI isoforms. Hybrid fibers are shown with 
white arrows (Fig. 8).  
 
                  
Figure 8. Hybrid fibers in normal EDL. Figure show cross sections staining with antibodies against (A) TnIs, 
(B) TnIf, (C) MyHC 1, (D) MyHC 2a, (E) MyHC 2x, and (F) MyHC 2b. White arrows indicate hybrid fibers that 
are positive for MyHC 1 and MyHC 2a. In figure B, E and F, hybrid fibers are indicated by an additional asterisks. 
Negative control sections stained only with secondary antibodies gave no fluorescence for any of the antibodies 
used (data not shown). Scale bar = 100µm. 
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3.1.3 TnI expression pattern in soleus. 
In soleus (Fig. 9), MyHC 1 expression was found to be co-expressed with TnIs. MyHC 2a 
fibers were shown to stain positive for both TnI isoforms, reveling that fast fibers in soleus 
appear hybrid with respect to TnI expression.  
 
                     
Figure 9. TnI and MyHC isoform expression in normal soleus. Serial cross sections of rat soleus stained with 
antibodies against (A) TnIs, (B) TnIf, (C) MyHC 1, and (D) MyHC 2a. Examples of a MyHC 1 and 2a positive 
fiber are denoted as (1.) and (2.), respectively. Note that MyHC 2a fibers are positive for both TnIs and TnIf. 
Negative control sections stained only with secondary antibodies gave no fluorescence for any of the antibodies 
used (data not shown). Scale bar = 100µm. 
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3.2 Overexpression of Ets-2 in soleus 
3.2.1 Verification of Ets-2 expression in cell culture. 
Expression and translation of the Ets-2 gene was tested in cell culture. HEK-293 cells were 
transfected with the experimental plasmid pEts-2 (Fig. 4d), and a sham group was transfected 
with an empty plasmid, pSHAM (Fig. 4e). Following protein extraction and native-PAGE, a 
western blot was run. The resulting blot was immunostained with an antibody against Ets-2, 
revealing a band of about 49 kDa in the lane transfected with pEts-2 (Fig. 10), a size consistent 
with the weight of the Ets-2 protein (Yu et al., 2009). No band was detected in the lane 
transfected with the sham plasmid.  
 
 
 
3.2.2 Fiber type and isoform distribution in soleus overexpressing Ets-2. 
Fourteen days after transfection, a total number of 452 fibers in three groups (normal control, 
sham and Ets-2) from 7 male Wistar rats were analyzed (Table 5). No change in fiber type 
distribution was significant when comparing the Ets-2 transfected, sham transfected and the 
normal control group. No semi-quantitative measurements of TnIf expression in Ets-2 
transfected fibers were performed, because the quality of the samples precluded quantification.  
 
Table 5. MyHC distribution in normal control, sham transfected and Ets-2 transfected soleus 
Fiber type: Normal control  Sham transfected  Ets-2 transfected 
   n:                %  n:               %     n:              % 
1 287             95.7  22             100  122           93.8 
2a   13               4.3    0                 0      8             6.2 
Total 300              100  22             100  130            100 
There was no staining for 1/2a, 2x or 2b MyHC so these are excluded from the table 
 
 
 
 
Figure 10. Expression of Ets-2 in tissue 
culture. Western blot of protein extracts 
from HEK-293 cells transfected with the Ets-
2 expression vector pEts-2 or the sham 
plasmid pSham. The 49 kDa band represent 
the Ets-2 protein, visualized with an Ets-2 
specific antibody. Staining with anti-Vinculin 
served as loading control.  
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3.3 Effects of siRNA mediated knock-down in EDL 
3.3.1 Verification of siRNA knockdown of Ets-2 in cell culture. 
In this experiment, four different RNAi vectors were co-transfected with pEts-2 into HEK-293 
cells. Two of the RNAi vectors were encoding siRNA targeting Ets-2 mRNA; the remaining 
two were encoding scrambled siRNA sequences, serving as negative controls. Cell lysates were 
run on gels and stained with an anti-Ets-2 antibody (Fig. 11a). The intensity values of the 
different bands were measured and compared with cells transfected with pEts-2 only (Fig. 
11b). The degree of knockdown was measured as 57% and 56% for siRNA 1 and siRNA 2, 
respectively (Fig. 11b).  
 
 
Figure 11.  Ets-2 knockdown in HEK293-cells. 
(A) Image of western blot. Upper row represents wells co-transfected with pEts-2 and RNAi vectors. Non-
transfected HEK-293 cells were used as negative control, while the most left lane (pEts-2) served as positive 
control. Bands were visualized with an anti-Ets-2 antibody. Bottom row served as a loading control. Bands were 
visualized using an antibody against Vinculin. (B) A semi-quantitative assessment showing the relative amount of 
Ets-2 protein. n=3, SEM. All band intensities were normalized against the positive control. Intensity of the Ets-2 
bands was normalized against the intensity of the vinculin band in the same well. Statistical differences are 
illustrated by dissimilar letters (p<0.05). 
 
A significant difference was found when comparing the positive control lane (Ets-2 only) with 
lanes co-transfected with Ets-2 and siRNA 1 or siRNA 2. The CMV promoter located within 
pEts-2 is optimized for high expression in mammalian cells (GenBank Accession #: U57606), 
and considering the low amount of Ets-2 transcripts present in muscle (Rana. et al., 2011), the 
siRNA vectors might be sufficient to knockdown Ets-2, in vivo. 
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3.3.2 Effects of siRNA knockdown of Ets-2 on fiber type distribution in EDL. 
A total number of 438 fibers in three groups (normal control, scramble, and RNAi transfected 
fibers) from 4 male Wistar rats were analyzed (Table 6). When comparing RNAi transfected 
fibers against normal and scramble control no significant differences were observed; however, 
a tendency towards a shift in the slow direction is seen in the siRNA transfected group. No 
significant change was found either when comparing fiber type populations in the normal 
against scramble control.  
 
Table 6. MyHC distribution in normal control, scramble transfected and siRNA 
transfected EDL 
Fiber type:     Normal Control: Scramble transfected: SiRNA transfected: 
     n:                   %:    n:                    %:   n:                       %: 
1     7                   2.8   10                    3.6   0                        0.0 
1/2a     1                   0.4     4                    1.4   0                        0.0 
2a   33                 13.4   39                  13.9   3                      25.0 
2a/2x   21                   8.5   19                    6.8   2                      16.7 
2x   55                 22.4   63                  22.5   2                      16.7 
2x/2b   28                 11.4   40                  14.3   2                      16.7 
2b 101                 41.1 105                  37.5   3                      25.0 
Total 246               100.0 280                100.0 12                    100.0 
 
 
Figure 12. Fiber type distribution in EDL. EDL after RNAi and scramble transfection, and in normal controls. 
Total n is 438 fibers from 4 different animals. Hybrid fibers are shown in shaded boxes. No significant differences 
were found when comparing RNAi to normal or scramble control fibers, nor when comparing scramble and 
normal control fibers. 
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3.3.3 Semi-quantitative assessment of TnIf expression in Ets-2 siRNA 
transfected fibers in EDL. 
The fluorescent intensity of siRNA and scramble transfected fibers was measured and 
compared against non-transfected control fibers. All siRNA- and scramble transfected fibers 
were of type 2 MyHC and were hence pooled (Fig. 13). A significant difference was found 
between the normal MyHC 1 and siRNA, scramble, and the normal MyHC 2 group. No 
significant differences were found between siRNA, scramble transfected and normal MyHC 2 
control fibers. A small reduction in intensity is seen in the siRNA transfected group, but no 
preferential reduction was seen in any of the MyHC 2 subtypes. 	  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 13. Relative intensity of TnIf. 
Figure represents the relative fluorescence 
intensity of fiber populations transfected 
with siRNA and scrambled siRNA 
sequences, compared with normal non-
transfected control fibers. All siRNA and 
scramble fibers were of type 2 MyHC and 
were hence pooled. A significant 
difference in intensity was found when 
comparing normal MyHC 1 against the 
other populations. No significant 
differences were found when comparing 
siRNA, scramble and normal MyHC 2.  
Mean± SEM. Statistical differences are 
illustrated by dissimilar letters (p<0.05). 
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4 Discussion 	  
4.1 Expression patterns of Troponin I 
In the current study we demonstrate that the fibrillar expression pattern of the two troponin I 
isoforms is muscle type-specific. This study shows that MyHC 2a fibers in the slow soleus 
express both TnI isoforms, while MyHC 2a fibers in EDL express only TnIf. The finding is in 
agreement with Dhoot and Perry et al. (1979), who reported that a progressive increase in TnI 
hybrids is observed in aging soleus. In 12 week old animals, one third of the type 2 positive 
cells were reported to be TnI hybrids, whereas in animals older then 20 weeks, less than 10 % 
of the type 2 fibers stained for the slow isoform (Dhoot and Perry, 1982). In the present study, 
animals were sacrificed at 16 weeks of age, though all MyHC 2a fibers investigated were TnI 
hybrids.  
 
On mRNA level, a study utilizing in situ hybridization with probes against the two TnI 
isoforms demonstrates that the labeling density of TnIs probes on type 2 fibers in soleus is 
higher when compared to fast fatigue resistant fibers in the fast plantaris muscle (Koppe et al., 
1989). These findings may explain the muscle type-specific expression pattern observed in the 
current study.  
 
It is well established that phenotypic variations may occur between the equal fiber types 
occurring in different muscles. (Larsson and Edstrom, 1986; Nakatani et al., 1999; Jouffroy et 
al., 2003). When comparing soleus and EDL, MyHC 2a fibers in soleus have a considerably 
larger cross sectional area than their counterparts in EDL (Larsson and Edstrom, 1986), 
demonstrating inter-muscular variation in MyHC 2a fibers of soleus and EDL. Thyroid 
hormone, T3, has been reported to influence MyHC 2a expression in a muscle type-specific 
manner (Izumo et al., 1986). Thyroid hormone causes an upregulation of MyHC 2a expression 
in soleus, but causes down regulation of the MyHC 2a gene with a different degree of 
sensitivity in fast-twitch muscles (Izumo et al., 1986). Denervation causes an increase in slow 
fibers expressing TnIf (Dhoot and Perry, 1982), this effect is counteracted by thyroidectomy 
(Dhoot and Perry, 1981). This indicates that T3 contributes to the differential regulation of the 
TnIf gene. 
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Due to the fact that soleus is a postural muscle, it would possibly be beneficial and more 
energy conserving if MyHC 2a fibers expressed both TnI isoforms, decreasing the twitch 
speed. In a study by R. Close (1967), measurements of the isometric twitch contraction times 
of single motor units demonstrated that the mean contraction time of fast fibers in EDL was 11 
msec*, compared to 38 and 17 msec for slow† and fast‡ motor units in soleus, respectively. 
These findings propose that MyHC 2a fibers in soleus are slower than their equivalents in 
EDL, a difference that might be explained by the presence of TnIs in fast-twitch soleus fibers. 
 
4.2 Trans activating abilities of Ets2 in slow fibers. 
In the current study, in vivo overexpression of Ets2 in soleus had no significant effect on either 
MyHC distribution or TnI expression in adult slow muscles. Since fast patterned activity is a 
feature associated with fast-twitch fibers (Hennig and Lomo, 1985), no selective translocation 
of Ets-2 occurs in type 1 fibers (Rana. et al., 2011), possibly attenuating its trans-activating 
ability. If we were to assume that Ets-2 binds the TnIf FIRE enhancer under such 
circumstances, activated NFATc1 might repress a putative effect of Ets-2 on TnIf transcription. 
NFAT has been shown to reduce transcription of reporter constructs harboring FIRE during 
slow patterned activity (Rana. et al., 2008), so it is therefore reasonable to assume that 
activated NFAT may repress transcription of the TnIf gene in vivo.  
 
Considering the fact that Ets-2 is naturally present in slow-twitch fibers (Rana. et al., 2011) 
(Fig. 3), one may assume that the trans-activational abilities of Ets-2 is under the regulation of 
post-translational modification, similar to MyoD (Ekmark et al., 2007). In cultured fibroblasts 
it has been demonstrated that stress induced elevation in [Ca2+]i induces CaMKII mediated 
phosphorylation of Ets-2, directly affecting its subcellular compartmentalization and trans-
activational abilities (Yu et al., 2009).  
 
 
 
 
 
 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
*, n = 48. 10.8 msec ±1.07 (± standard deviation) 
†, n = 34. 38.0 msec ± 3.70      
‡,  n = 4. 17.4 msec ± 1.70 
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4.3 Knockdown of Ets-2 in EDL 
Due to low transfection efficiency, we were not able to determine whether knockdown of Ets-2 
had an effect on fiber type distribution. However, a small increase in MyHC 2a fibers at the 
expense of 2x fibers was observed. Even though the sample size is small, the transition is in the 
slow direction, consistent with the hypothesis that Ets-2 maintains fast gene expression.  
 
Whether knockdown of Ets-2 had an effect on TnIf expression in fast fibers is hard to interpret 
from these results; no significant decline in TnIf intensity was observed in type 2 MyHC fibers 
transfected with siRNA. In EDL, it has been demonstrated that the residual expression of TnIf 
remains around 50% two weeks after denervation (Rana et al., 2005). Under these 
circumstances, lack of fast patterned activity would cause a decline in the nuclear/cytoplasmic 
ratio of Ets-2 (Rana. et al., 2011). Rana et al. (2011) demonstrated that siRNA mediated 
knockdown of Ets-2 caused an approximately 50% decrease in the activity of reporter 
constructs harboring FIRE. These findings suggest that Ets-2 is necessary for high-level 
expression in fast-twitch fibers, consistent with our results. However, a reduction in 
transcription does not necessarily reflect a reduction in protein concentration (Lunde et al., 
2011). Based on these findings, knockdown might cause a reduced transcription that we were 
not able to detect under the experimental setup. 
 
4.4 Future prospects 
Since the material in the knockdown was small due to variable transfection efficiency, future 
studies should focus on increasing the sample size. In the last decade, vector based 
recombinant adeno-associated viruses has emerged as a tool for exogenous gene transfer in 
skeletal muscle, providing high transduction efficiency (Blankinship et al., 2004). Commercial 
companies such as GenScript may provide viral vectors designed for overexpression or 
knockdown of desired genes. With a higher transfection (or transduction) efficiency it would 
have been interesting to quantify TnIf and Ets-2 transcripts in siRNA transfected fibers 
(Wacker et al., 2008), such investigations could further supported our findings. It would have 
been interesting to use mass spectrometry to investigate possible modifications of the Ets-2 
protein, isolated from fast-twitch and slow-twitch single fibers (Yu et al., 2009; Bantscheff et 
al., 2012). 
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4.5 Conclusions 
• Fast MyHC 2a fibers in soleus express TnIs and TnIf, while MyHC 2a fibers in EDL 
express only TnIf 
• Overexpression of Ets-2 has no effect on MyHC fiber type distribution in soleus. 
• Knockdown of Ets-2 has no significant effect on MyHC fiber type distribution or TnIf 
expression in EDL. 	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5 Appendices 
 
5.1 DNA electroporation solutions 
5.1.1  pEts-2 and pAP-LacZ solution (200 µl) 
Solution: Amount: 
pEts-2 in TE buffer (2 µg/µl)   25 µl 
pAP-lacZ in TE buffer (2 µg/ul)   25 µl 
4 M NaCl     8 µl 
dH2O 142 µl 
 
5.1.2 pSHAM and pAP-LacZ solution (200 µl) 
Solution: Amount: 
pSHAM in TE buffer (2 µg/µl)   25 µl 
pAP-lacZ in TE buffer (2 µg/µl)   25 µl 
4 M NaCl     8 µl 
dH2O 142 µl 
 
5.1.3 RNAi vector and pAP-LacZ solution (200 µl) 
Solution: Amount: 
RNAi vector in TE buffer (2 µg/µl)   25 µl 
pAP-lacZ in TE buffer (2 µg/ul)   25 µl 
4 M NaCl     8 µl 
dH2O 142 µl 
 
5.2 siRNA inserts 
RNAi vector: siRNA sequence: 
siRNA 1 5´- AACGAGTTCAGCCTGGTGAAT - 3 
scramble 1 5´- GTATGACGACGAACTCGTGTA - 3 
siRNA 2 5´- AACGGCCAGATGCTGTGTAAC - 3 
scramble 2 5´- GGACTTGCTCGATACACGGAA - 3 
Sequences were cloned into the vector pRNA-CMV3.1/Neo 
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5.3 Cell culture 
5.3.1  Cell lysis buffer 
Solution:     Amount: 
50 mM Trisacetate pH 7 12 g      12.00 g 
0,27 M Sucrose 184.4 g    184.40 g 
1 mM EDTA 0.75 g        0.75 g 
1 mM EGTA 0.76 g        0.76 g 
1 mM Sodium Orthovanadate       20 ml stock 
10 mM B-glycerophosphate         6.30 g 
50 mM Sodium Fluoride         4.20 g 
5 mM Sodium Pyrophosphate         4.46 g 
1 % Triton X-100       20.00 ml 
• Make up to 2.0 l with distilled water.  
• Before use (per 50 ml buffer), add 50 µl of protease inhibitor phenylmethane-
sulphonylfluoride (PMSF), 4mM Benzamidine and β-mercaptoethanol. 
 
5.3.2  10% FCS DMEM (Dulbecco's Modified Eagle Medium) 
Solution: Amount: 
DMEM (GIBCO) 500 ml 
Fetal calf serum (Bio Whittaker)   50 ml 
Penicillin/Streptomycin (Bio Whittaker)     5 ml 
 
5.4 Western blotting 
5.4.1  10X transfer buffer solution 
Solution: Amount: 
Tris-(hydroxymetyl)aminomethane   60 g 
Glycine 288 g 
• Dissolve Tris and Glycine in 800 ml dH20 before adjusting to 1.0 l. 
• To make 1X transfer buffer, take 100 ml 10X transfer buffer, 100ml methanol and 800 ml 
dH20. 
 
5.4.2  10X TBS solution (Tris-buffer saline) and TBS-T 
Solution: Amount: 
Tris-(hydroxymetyl)aminomethane   24.25 g 
NaCl 292.20 g 
• Dissolve NaCl and Tris in 800 ml dH20 before adjusting to 1.0 l. 
• To make TBS-T, take 100 ml of 10X TBS and 900 ml dH20, then add 1ml Tween20 (P1379, 
Sigma-Aldrich), mix well. 
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5.5 Histochemistry 
5.5.1  10X PBS (phosphate-buffered saline) solution 
Solution: Amount: 
NaCl 80.0 g 
KCl   2.0 g 
Na2HPO4 x 2H20 14.4 g 
KH4PO4   2.0 g 
• Dissolve salts in 800 ml of dH20 
• Adjust volume to 1.0 l, and then the pH to 6.8 
 
5.5.2 Staining for MyHC isoforms 
• Remove sections from -80oC freezer and let the sections thaw for 30 min before removing 
the surrounding foil. 
• Apply antibodies for the different MyHC isoforms. 
 
MyHC antibodies and staining conditions 
MyHC: Primary antibody: Concentration: Incubation: 
1 BA-D5 1:50 in 1% BSA in PBS 1 hour RT 
2a SC-71 1:50 in 1% BSA in PBS 1 hour RT 
2x 6H1 100% Overnight, 4oC 
2b BF-F3 100% 45 min 37oC 
 
• Wash sections 3 x 5 min in PBS (pH 7.2). 
• Use secondary antibody Rabbit anti-mouse IgG FITC conjugated (F-9137, Sigma) on 
primary antibodies BA-D5 and SC-71, in a 1:200 dilution in 1% BSA in PBS. Incubate for 1 
hour at 37oC in a moist chamber. 
• Use secondary antibody Goat Anti-mouse IgM FITC conjugated (F-9259 SIGMA) on 
primary antibodies 6H1 and BF-F3, in a 1:200 in 1% BSA in PBS. Incubate for 1 hour in a 
37oC moist chamber. 
• Wash sections 3 x 5 min in PBS (pH 7.2). 
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5.5.3 Staining for Troponin isoforms 
• Remove sections from -80oC freezer and let the sections thaw for 30 min before removing 
the surrounding foil. 
• Use a hydrophobic slide marker (H-400, Vector) to encircle the groups of sections. 
• Hydrate the sections in 5% BSA in PBS for 2 hours at room temperature. 
• Apply antibodies for the different troponin isoforms. 
 
Troponin I antibodies and staining conditions 
TnI	  isoform:	   Primary	  antibody:	   Concentration:	   Incubation:	  
Troponin	  I	  fast	   Ab134838	   1:1000	  in	  2%	  BSA	  in	  PBS	   Over	  night,	  4oC	  
Troponin	  I	  slow	   Ab97711	   1:1000	  in	  2%	  BSA	  in	  PBS	   Over	  night,	  4oC	  
 
 
• Wash sections 3 x 10 min in PBS (pH 7.2). 
• Use secondary antibody Donkey Anti-sheep, Alexa Fluor® 488 (A11015, Invitrogen) on 
primary antibody Ab134838, in a 1:200 dilution in 1% BSA in PBS. Incubate for 1 hour at 
37oC in a moist chamber. 
• Use secondary antibody Goat Anti-rabbit IgG FITC/TRITC conjugated (T6778 Sigma or 
F987, Sigma) on primary antibody Ab97711, in a 1:200 in 1% BSA in PBS. Incubate for 1 
hour in a 37oC moist chamber. 
• Wash sections 3 x 5 min in PBS (pH 7.2). 
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5.5.4 Staining for β-galactosidase activity 
• Remove sections from -80oC freezer and let the sections thaw for 30 min before removing 
the surrounding foil. 
• Use a hydrophobic slide marker (H-400, Vector) to encircle the groups of sections. 
• Make X-gal fix solution. 
 
X-gal fixative solution 
Solution:   Amount: 
Formaldehyde 36% (Rectapur)     4.0 ml 
Glutaraldehyde 50% (EMS)     0.5 ml 
1X PBS, pH 7.2 196.0 ml 
 
• Add a few drops of ice-cold fix solution for 4 min in a fume hood. 
• Wash slides thoroughly 3 x 10 min in PBS. 
• Make X-gal staining solution. 
 
X-Gal staining solution 
Solution:    Amount: 
0.2 M Potassium ferricyanide     30 µl 
0.2 M Potassium ferrocyanide     30 µl 
1.0 M Magnesium cloride       3 µl 
10X PBS (pH 6.8)   150 ml 
dH20 1260 µl 
X-gal DMSO (50µg/µl) (Promega)     30 µl 
 
• Stain overnight at 32oC in a moist chamber. 
• Wash sections 3 x 5 min in PBS. 
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